79% of Canadians support the therapeutic use of psilocybin for people at the end of life

From Université Laval 31/01/24 Nearly 4 out of 5 Canadians believe that the use of psilocybin, the active ingredient in hallucinogenic mushrooms, is an acceptable medical approach to treat existential distress in patients suffering from a serious and incurable disease. This is the main conclusion of an online survey of 2,800 people conducted by a […]

Subscribe to our weekly newsletter

Recieve the latest innovation, emerging tech, research, science and engineering news from Superinnovators.